Funding for this research was provided by:
Defence Health Foundation
Sir Edward Dunlop Medical Research Foundation
Received: 24 June 2020
Accepted: 20 July 2020
First Online: 6 August 2020
Ethics approval and consent to participate
: This project has been approved by the Human Research Ethics Committees of Austin Health (approval 16/Austin/188) and The Melbourne Clinic (approval 305). All participants will give written informed consent.
: Not applicable.
: MB is supported by a NHMRC Senior Principal Research Fellowship (1059660 and 1156072).MB has received Grant/Research Support from the NIH, Cooperative Research Centre, Simons Autism Foundation, Cancer Council of Victoria, Stanley Medical Research Foundation, Medical Benefits Fund, National Health and Medical Research Council, Medical Research Futures Fund, Beyond Blue, Rotary Health, A2 milk company, Meat and Livestock Board, Woolworths, Avant and the Harry Windsor Foundation, has been a speaker for Astra Zeneca, Lundbeck, Merck, Pfizer, and served as a consultant to Allergan, Astra Zeneca, Bioadvantex, Bionomics, Collaborative Medicinal Development, Lundbeck Merck, Pfizer and Servier – all unrelated to this work.CN has served as a consultant for Lundbeck, Grunbiotics, Servier, Janssen-Cilag, Wyeth and Eli Lilly, received research grant support from Wyeth and Lundbeck, and speaker honoraria from Servier, Lundbeck, Bristol-Myers Squibb, Organon, Eli Lilly, GlaxoSmithKline, Janssen- Cilag, Astra-Zenaca, Wyeth, and Pfizer.The other authors declare they have no competing interests.